US Binary Option SitesUK Binary Option Sites

Archive

U.S. Continues To See U.K As A Key Alliance Partner Post Brexit

Recent supportive comments made by U.S. officials in the aftermath of the Brexit vote show that the United States (U.S) is unlikely to act on previous threats that it would downgrade its relationship with the United Kingdom. President Barack Obama

Read More

Accenture beats Q3 estimates, raises FY16 EPS outlook

Last week, multinational management consulting services company Accenture plc (ACN) reported its fiscal 2016 third-quarter results that exceeded analysts’ estimates. However, the share price of Accenture has lost more than 8% or $10 per share in the last two trading

Read More

Housing Market in UK Set To See More Foreign Investors After Brexit

The British vote for exiting the European Union has resulted in the pound dropping to its lowest level in 30 years along with multiple market crashes across the world. Property prices in Britain are also expected to drop consequently, opening

Read More

Finisar beats Q4 estimates, issues strong Q1 outlook

Last week, Fiber optic technology company Finisar Corp. (FNSR) reported its fiscal 2016 fourth-quarter earnings and revenue that comfortably exceeded the estimate of analysts. The reported 16% gain in the earnings per share, on a y-o- y basis, was the

Read More

Casey’s report strong Q4 same-stores sales growth

Casey's General Stores, Inc. (CASY) reported its fiscal 2016 fourth-quarter revenue that beat the analysts’ estimates. However, the earnings missed the Wall Street consensus by a single cent. Since the reported earnings were below the market’s expectations, the share price

Read More

World Bank Revises Global Growth Estimates Amidst Weak Demand

The World Bank has slashed the forecast for global growth again putting it at 2.4 percent, a decline from the 2.9 percent it had predicted in January this year. This estimate is more pessimistic than that of the International Monetary

Read More

Exelixis spikes on positive Phase 3 study of cancer drug

The shares of genomics-based biopharmaceutical company Exelixis (EXEL) recorded a new 12-month high of $7.34 yesterday. The reason for the 11.23% gain in the share price is the positive result in the Phase 3 trial of kidney cancer drug Cabometyx.

Read More

Financial Conduct Authority Asked To Look Into Peer-To- Peer Lending

Andrew Tyrie, chairman of the treasury committee in Britain's parliament has written to Tracey McDermott, acting chief executive of the Financial Conduct Authority (FCA), which is the UK securities regulator expressing concern at the rising risks in the crowdfunding and

Read More

SoftBank To Ramp Up Speed Of Investments Into India

SoftBank, the Japanese telecom and Internet major has said that its investment commitment to India over the next 5-10 years is likely to exceed $10 billion. The company has recently announced that it will be making its first investment into

Read More